Q-Line Biotech Ltd share price logo

Q-Line Biotech Ltd

NSE: QLINE

Small Cap

₹637.60

+18.05

(+2.91%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Q-Line Biotech Stock Performance

as on September 3, 2026 at 9:32 pm IST

  • Day's Low

    Day's High

    ₹622.00
    ₹659.75
    downward going graph

    2.45%

    Downside

    3.47%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹431.00
    ₹659.75
    downward going graph

    32.40%

    Downside

    3.47%

    Upside

    downward going graph

Q-Line Biotech share price movements today

Previous Close
₹619.55
Open
₹626.00
Volume
3.30L
Upper Circuit
₹743.45
Lower Circuit
₹495.65
Day's Low - High
₹622.00 - ₹659.75
52 Week Low - High
₹431.00 - ₹659.75

Q-Line Biotech Historical Returns

1 Month Return
+ 12.22 %
3 Month Return
+ 34.49 %
1 Year Return
+ 30.54 %
3 Year Return
+ 30.54 %
5 Year Return
+ 30.54 %

Q-Line Biotech Fundamentals

as on September 3, 2026 at 4:02 pm IST

Market Cap

₹1,445.30 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Industry PE ratio

-

Beta (LTM)

0.03

P/B Ratio

0

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

0

EPS (TTM)

0

Book Value

0

Q-Line Biotech Technical Analysis

Track how Q-Line Biotech technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day

Technicals Summary

Bearish

Neutral

Bullish

Neutral

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish6
Bullish6
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
2.3
Bullish
CCI (20)
56.94
Neutral
RSI (14)
53.03
Neutral
Momentum (10)
2.15
Bearish
ADI (14)
42.99
Bullish
Ultimate Oscillator (7,14,28)
45.99
Neutral

Moving Averages

Name

Value

Action

SMA (20)
636.14
Bullish
EMA (20)
637.12
Bearish
VWMA (20)
638.22
Bearish
SMA (50)
633.15
Bullish
EMA (50)
635.4
Bullish
SMA (200)
640.29
Bearish
EMA (200)
637.66
Bearish
KAMA (200)
633.43
Bullish
DEMA (200)
638.76
Bearish

Q-Line Biotech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Q-Line Biotech with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Q-Line Biotech Ltd image
Q-Line Biotech Ltd
NA1,445.306.11%0.7424313
Apollo Ingredients Ltd image
Apollo Ingredients Ltd
NA79.46338.69%0.00-14
MFS Intercorp Ltd image
MFS Intercorp Ltd
NA5.613.12%0.00-12
Darjeeling Industriies Ltd image
Darjeeling Industriies Ltd
NA21.3195.07%0.00-1NA
Asian Tea & Exports Ltd image
Asian Tea & Exports Ltd
NA24.52-6.66%0.60153
See all

Q-Line Biotech Stock’s Investor Sentiment and Interest

Search interest for Q-Line Biotech Ltd Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:15% versus previous 30 day period

Q-Line Biotech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2025
Mar 2026
Sales
88.62
109.32
Other Income
1.41
1.62
Total Income
90.03
110.94
Expenses
59.49
77.36
Operating Profit
29.13
31.96
Operating Profit Margin %
32.87%
29.24%
Profit Before Interest, Tax and Depreciation
30.54
33.57
Interest
5.03
6.08
Depreciation
2.21
4.49
Profit Before Tax
23.3
23
Tax Paid
5.93
5.98
Profit After Tax
17.38
17.03
Total Net profit including share of profit / Loss from associate company
17.38
17.03
EPS
10.68
10.46
Actual EPS
10.68
10.46
Adjusted EPS
10.68
10.46

Q-Line Biotech Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
182.74
203.65
313.14
341.74
Other Income
2.08
2.8
8.83
5.7
Total Income
184.81
206.45
321.97
347.44
Expenses
149.04
165.64
265.29
244.68
Operating Profit
33.7
38.01
47.85
97.06
Operating Profit Margin %
18.44%
18.66%
15.28%
28.4%
Profit Before Interest, Tax and Depreciation
35.77
40.8
56.68
102.76
Interest
3.8
6.28
14.91
19.42
Depreciation
2.14
3.93
7.03
10.79
Profit Before Tax
29.83
30.59
34.74
72.55
Tax Paid
8.46
8.96
19.06
16.83
Profit After Tax
21.38
21.64
15.68
55.72
Total Net profit including share of profit / Loss from associate company
32.09
34.44
19.21
55.72
EPS
20.38
218.72
121.97
34.79
Actual EPS
20.38
218.72
121.97
34.79
Adjusted EPS
20.38
218.72
12.2
34.79
Diluted EPS
20.38
218.72
121.97
34.79

Q-Line Biotech Ltd Cash Flow

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
24.97
-24.18
-1.32
Cash Flow from Investing Activities
-26.31
-44.69
-59.09
Cash Flow from Financing Activities
26.39
16.99
53.34
Net Cash Flow
25.06
-51.88
-7.07

Q-Line Biotech Stock Shareholding Pattern

Numbers in percentages

Sep 2025
May 2026
Promoters
96.77%
67.51%
DII
0%
10.14%
FII
0%
1.67%
Public
0%
19.33%
Total Outstanding Shares
1,62,74,999
2,33,28,199
Total Shareholders
24
3,497

Mutual Funds that own Q-Line Biotech Stock

Check out the Mutual Funds with significant holdings in Q-Line Biotech.

Funds
Holdings
Shares Held
Abakkus Small Cap Fund Direct Growth
Abakkus Small Cap Fund Direct Growth
1.24%
484400

Insights on Q-Line Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.00% to 1.67% in May 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, QLINE stock has moved up by 17.3%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 0.00% to 19.33% in May 2026 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.00% to 1.59% in May 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 96.77% to 67.51% in May 2026 quarter

About Q-Line Biotech Ltd

QLine Biotech Limited was originally incorporated as POCT Services Private Limited on November 10 2010 as a Private limited company dated November 10 2010 issued by the Assistant Registrar of Companies Uttar Pradesh and Uttarakhand. Subsequently the name of Company was changed to QLine Biotech Private Limited on July 23 2021. Further Company was converted from a private company to public company andthe name of Company was changed to QLine Biotech Limited via fresh certificate of incorporation dated March 08 2025 issued by Central Processing Centre.The Company is engaged in the business of developing manufacturing and marketing of diverse range of reagents including kits and POC devices consumables and manufacturing importing distribution/supply of diagnostic equipment for different diagnostic healthcare needs. Company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributors majorly to diagnostic service providers hospitals and medical colleges. The core segments of operations of the Company in IVD Industry include Clinical Chemistry Haematology Immunodiagnostics Molecular Diagnostics and Others POC Devices Rapids.The Company established first manufacturing plant at Bawana New Delhi in 201617. Further during the year 2019 it incorporated POCT Science House Private Limited to engage in the business of running diagnostic laboratories. Since 2021 the facilities have been subject to regular inspections and audits by regulators including the CDSCO State Drug Authority Intertek URS Certification Limited and other European regulatory agencies conducted on a periodic basis. As a part of growth strategy Company incorporated subsidiary companies namely QLine Iris Private Limited which are engaged in the business of Radiology Imaging Services which was established in the year 2023. However during the financial year 2025 Company has sold the controlling stake in QLine Nutraceuticals Private Limited to focus on the core business. The Company has acquired a manufacturing plant at Lucknow Uttar Pradesh in 2025. Company is planning a fresh issue IPO of 7053200 equity shares of Rs 10 each..

Revenue: ₹109.32Cr as on March 2026 (Q4 FY26)
Net Profit: ₹17.03Cr as on March 2026 (Q4 FY26)
Listing date: 29 May, 2026
OrganisationQ-Line Biotech Ltd
IndustryTrading
E-voting on sharesClick here to vote

FAQs

What is Q-Line Biotech share price today?

Q-Line Biotech share price today stands at ₹637.6 as on at the close of the market. Q-Line Biotech share today touched a day high of ₹659.75 and a low of ₹622.

What is the 52 week high and 52 week low range for Q-Line Biotech share?

Q-Line Biotech touched a 52 week high of ₹659.75 and a 52 week low of ₹431. Q-Line Biotech share price today i.e. is closed at ₹637.6, which is -3.36% down from its 52 week high and 47.94% up from its 52 week low.

What is Q-Line Biotech's market capitalisation today?

Q-Line Biotech market capitalisation is ₹1,445.30 Cr as on .

How to buy Q-Line Biotech shares?

To buy Q-Line Biotech shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for QLINE or Q-Line Biotech Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Q-Line Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Q-Line Biotech trading volume today?

Q-Line Biotech trading volume is 3.30L as on . This means that 3.30L shares of Q-Line Biotech were bought and sold on the stock market during today's trading session.